Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer (CECAVI)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2015 by Odense University Hospital
Sponsor:
Collaborator:
Odense University Hospital
Information provided by (Responsible Party):
Per Pfeiffer, Odense University Hospital
ClinicalTrials.gov Identifier:
NCT01020864
First received: November 25, 2009
Last updated: January 20, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)